James is delighted to be joined by the accomplished Dr. Paul-Peter Tak, currently serving as the Venture Partner at Flagship Pioneering and holding the esteemed position of CEO at Kintai Therapeutics. Dr. Tak boasts an impressive career spanning more than 25 years in the life sciences sector, during which he has played instrumental roles in creating and leading multiple companies. Notably, from 2011 to 2017, Dr. Tak served as the founder and senior vice president, heading the immuno-inflammation therapy area unit at GSK. His leadership during this period resulted in the introduction of over 10 new mechanisms of action into clinical trials, marking a significant contribution to the field. Subsequently, from 2016 to 2018, Dr. Tak assumed key roles as senior vice president of R&D pipeline, chief immunology officer, development leader, and co-chair of GSK’s scientific review board. In these capacities, he oversaw the strategic development of a ground-breaking portfolio of medicines in oncology, with a specific focus on immuno-oncology, epigenetics, and cell and gene therapy. This extensive and impactful journey in the life sciences positions Dr. Paul-Peter Tak as a distinguished figure in the industry, and his insights promise to provide a wealth of knowledge on the podcast.
Listen to the podcast: https://podcasts.apple.com/us/podcast/episode-35-story-flagship-pioneering-future-medicines/id1438968893?i=1000446446139
